Market Research Assistance
- + 1-888-391-5441
- [email protected]
On the Web 
cancer therapeutics Market Research Reports
cancer therapeutics Market Research Reports
| Title | published | price | |
|---|---|---|---|
Squamous Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... ine landscape.
The report provides comprehensive information on the therapeutics under development for Squamous Cell Carcinoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administrati......" | 02-May-2022 | $2500 | |
Squamous Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... ous Non-Small Cell Lung Cancer pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Squamous Non-Small Cell Lung Cancer, complete with analysis by Stage of Development, Drug Target, ......" | 02-May-2022 | $2500 | |
T-Cell Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... />
The report provides comprehensive information on the therapeutics under development for T-Cell Leukemia, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The ......" | 02-May-2022 | $2000 | |
T-Cell Lymphomas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "......
The report provides comprehensive information on the therapeutics under development for T-Cell Lymphomas, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. ......" | 02-May-2022 | $2500 | |
Hepatic (Liver) Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... ndscape.
The report provides comprehensive information on the therapeutics under development for Hepatic (Liver) Tumor, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA)......" | 02-May-2022 | $2000 | |
Recurrent Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Recurrent Medulloblastoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Admi......" | 02-May-2022 | $2000 | |
High-Grade Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... />
The report provides comprehensive information on the therapeutics under development for High-Grade Glioma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Ty......" | 02-May-2022 | $2000 | |
Tenosynovial Giant Cell Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... t Cell Tumor pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Tenosynovial Giant Cell Tumor, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA......" | 02-May-2022 | $2000 | |
Hormone-Sensitive Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... ensitive Prostate Cancer pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Hormone-Sensitive Prostate Cancer, complete with analysis by Stage of Development, Drug Target, Mechanis......" | 02-May-2022 | $2000 | |
Transitional Cell Carcinoma (Urothelial Cell Carcinoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... layers provides an overview of the Transitional Cell Carcinoma (Urothelial Cell Carcinoma) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Transitional Cell Carcinoma (Urothelia......" | 02-May-2022 | $2500 | |
| | |||